UPClytics
Alle Fälle anzeigen

UPC CFI 106/2025

28. Feb. 2025·EP3156843 · DEVICE AND METHOD FOR THREE-DIMENSIONAL RECONSTRUCTION OF THE HEAD AND BODY

Verfahrensdetails
Status
Case Closed (Patent wie erteilt aufrechterhalten)
Verfahrensart
Widerklage auf Nichtigkeit
Kategorie
Widerklage auf Nichtigkeit
Parteien
Kläger
Vertreter
Division
Dusseldorf LD
Technologie
  • Instruments
    Optics
Sprache
German
Erste Entscheidung
23. Apr. 2026
Im Vergleich
Die Bilanz des Gerichts für diese Art von Verfahren, gezählt in erstinstanzlichen Entscheidungen. Eine Zahl in Klammern gibt an, auf wie vielen Entscheidungen eine Quote beruht.
Patent nichtigMedian Tage bis zur ersten Entscheidung
Gesamt-UPC37% (34/91)124
Dusseldorf LDGesperrtGesperrt
Richter Ronny ThomasGesperrtGesperrt
Richter Jule SchumacherGesperrtGesperrt
Richter Peter AgergaardGesperrtGesperrt
Richter Stefan WilhelmGesperrtGesperrt

Vor dem UPC: Canfield Scientific GmbH (4 Verfahren)·QUANTIFICARE S.A. (5 Verfahren)

Dieser Streit umfasst 3 weitere Verfahren

UPC CoA 110/2026·UPC CoA 99/2026·UPC CFI 559/2024

1 weitere Beklagte zum selben oder einem verwandten Patent

UPC CFI 3035/2026

Starten Sie die kostenlose Testphase, um die Ausgänge zu sehen.

Weitere Verfahren: Dusseldorf LD·2025

Entscheidungen
  • 2026-04-23
    Counterclaim for revocationÖffentlich

    Zusammenfassung: The UPC Local Division Düsseldorf found that EP 3 156 843 (a stereophotogrammetry device and method for 3D body reconstruction) was directly infringed by the respondents' Canfield Vectra H2 imaging system in Belgium, France, Italy, and the Netherlands. The court granted an injunction, recall, removal from distribution channels, disclosure of information, provisional damages of EUR 20,000, and a declaration of liability for further damages, while dismissing the defendants' counterclaim for revocation in its entirety.

    Rechtsfragen anzeigen (11)
    • Infringement of claims 1 and 14 of EP 3 156 843 by Canfield Vectra H2 stereophotogrammetry system
    • Territorial scope of UPC injunction under Art. 34 UPCA including 'carve out' of Germany due to parallel German proceedings
    • Claim construction: whether dual optics require two separate optical systems without moving parts
    • Claim construction: whether the signalling of target distance requires two temporally separate steps
    • Validity of EP 3 156 843: lack of inventive step counterclaim by respondents
    • Standing/passive legitimation of Defendant 1 (German subsidiary) for acts in other contracting member states
    • Limitation/prescription under Art. 72 UPCA for damages and ancillary claims
    • Provisional damages under R. 119 RoP
    • Provisional reimbursement of costs under R. 150.2 RoP
    • Security for enforcement under Art. 82(2) UPCA
    • Confidentiality order as condition precedent to disclosure obligation
DokumenttitelDatumÖffentlich
Receipt2026-06-23Nicht öffentlich
Cover sheet2026-06-23Nicht öffentlich
Document Claimant2026-06-23Nicht öffentlich
Receipt2026-05-18Nicht öffentlich
Cover sheet2026-05-18Nicht öffentlich
Exhibit Applicant2026-05-18Nicht öffentlich
Application document Applicant2026-05-18Nicht öffentlich
Verfahren abgeschlossen2026-04-23Nicht öffentlich
Entscheidung2026-04-23Nicht öffentlich
Decision2026-04-23Öffentlich
Angenommene Argumente
Was das Gericht akzeptiert hat — nach Partei.
  • An infringing act established in one Contracting Member State (Germany, even under a procedural 'carve out') is sufficient to issue an injunction covering all Contracting Member States where the patent is in force under Art. 34 UPCA

    KlägerRechtsgrundlage: Art. 34 UPCA
  • The dual optics feature of claim 1 does not require two separate optical systems without moving parts; the patent's teaching exploits depth of field and claim 1 does not exclude moving parts

    KlägerRechtsgrundlage: Art. 69 EPC / claim construction principles
  • Convergence of light beams at the target distance constitutes the required 'signalling' under claim 1 without a temporally separate second step

    KlägerRechtsgrundlage: Art. 69 EPC / claim construction
  • Infringement of claims 1 and 14 by Canfield Vectra H2, including use of the method in clinical study support and training

    KlägerRechtsgrundlage: Art. 25(a) and 25(b) UPCA
  • No prescription under Art. 72 UPCA because claimant only acquired knowledge of infringing acts in July/August 2020 (when infringement analysis and warning letter were issued)

    KlägerRechtsgrundlage: Art. 72 UPCA
  • Provisional damages of EUR 20,000 are warranted under R. 119 RoP to cover anticipated costs of the quantum proceedings

    KlägerRechtsgrundlage: R. 119 RoP; Art. 68 UPCA
  • Provisional cost reimbursement of EUR 90,000 for the counterclaim for revocation is justified at 50% of the reimbursement ceiling

    KlägerRechtsgrundlage: Art. 69(1) UPCA; R. 150.2 RoP
Zurückgewiesene Argumente
Was das Gericht nicht akzeptiert hat — und warum.
  • Lack of inventive step of EP 3 156 843 based on multiple prior art combinations including Wolf 'Elements of Photogrammetry', VECTRA H1 User Guide, WO 2010/012722, WO 2010/097572, and related art

    BeklagterRechtsgrundlage: Art. 138(1)(a) EPC; Art. 65 UPCA
  • Claim 1 requires dual optics without moving parts and with two fully separate optical systems

    BeklagterRechtsgrundlage: Art. 69 EPC / claim construction
  • Signalling must be a distinct temporally separate step following establishment of target distance

    BeklagterRechtsgrundlage: Art. 69 EPC / claim construction
  • Claimant lacked passive standing against Defendant 1 for acts in non-German contracting member states because only German infringement was alleged and Germany was carved out

    BeklagterRechtsgrundlage: Art. 34 UPCA
  • Injunction should be territorially limited per defendant to countries where that defendant's infringing acts were individually proven

    BeklagterRechtsgrundlage: Art. 34 UPCA; UPC_CFI_440/2023
  • Claims for damages and ancillary relief accruing before 26 September 2019 are time-barred under Art. 72 UPCA

    BeklagterRechtsgrundlage: Art. 72 UPCA
  • Enforcement should be stayed pending provision of a bank guarantee of EUR 1,800,000 due to catastrophic potential harm to respondents

    BeklagterRechtsgrundlage: Art. 82(2) UPCA; R. 352.1 RoP
  • Disclosure obligation should be subject to a confidentiality order restricting access to claimant's legal representatives and one non-sales employee

    BeklagterRechtsgrundlage: Art. 67 UPCA
  • Three US family patents were held invalid by the PTAB in IPR proceedings on substantially the same prior art, indicating the patent lacks inventive step

    BeklagterRechtsgrundlage: Art. 138(1)(a) EPC